Sunflower Pharmaceutical Group Co., Ltd. (SHE:002737)
China · Delayed Price · Currency is CNY 11.81
-0.09 (-0.76%)
Nov 13, 2026, 3:04 PM CST
SHE:002737 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 2,753 | 2,318 | 3,377 | 5,700 | 5,095 | 4,461 |
Revenue Growth | 31.44% | -31.36% | -40.76% | 11.89% | 14.20% | 28.86% |
Gross Profit Gross Profit Growth | 1,374 | 846.29 | 1,481 | 3,208 | 2,938 | 2,639 |
Operating Income Operating Income Growth | -186.07 | -291.57 | 452.83 | 1,184 | 1,022 | 771.33 |
Net Income Net Income Growth | -140.75 | -257.83 | 492.05 | 1,119 | 867.22 | 704.74 |
Earnings Per Share EPS Growth | -0.23 | -0.44 | 0.84 | 1.92 | 1.48 | 1.21 |
EPS Growth | - | - | -56.25% | 29.73% | 22.31% | 21.00% |
Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Intersegment Elimination Intersegment Elimination Growth | -1,666 |
Other Other Growth | 331.59 |
Medicine Medicine Growth | 3,652 |
Total Total Growth | 2,318 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 2,588 | 2,608 | 2,298 | 3,602 | 3,847 | 2,293 |
Total Debt Total Debt Growth | 214 | 115.93 | 8.99 | 26.52 | 436.08 | 244.08 |
Net Cash (Debt) Net Cash Growth | 2,374 | 2,492 | 2,289 | 3,576 | 3,411 | 2,049 |
Net Cash Growth | 9.70% | 8.85% | -35.97% | 4.82% | 66.47% | 37.72% |
Net Cash Per Share Net Cash Per Share Growth | 3.86 | 4.25 | 3.91 | 6.13 | 5.82 | 3.52 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 436.25 | 574.97 | -307.48 | 889.69 | 1,975 | 865.23 |
Capital Expenditures CapEx Growth | -105.53 | -96.1 | -92.79 | -149.16 | -152.9 | -118.31 |
Free Cash Flow Free Cash Flow Growth | 330.72 | 478.86 | -400.27 | 740.52 | 1,822 | 746.92 |
Free Cash Flow Growth | 44.24% | - | - | -59.37% | 144.00% | -21.96% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 49.93% | 36.51% | 43.85% | 56.27% | 57.67% | 59.15% |
Operating Margin | -6.76% | -12.58% | 13.41% | 20.76% | 20.07% | 17.29% |
Pretax Margin | -5.40% | -11.70% | 18.79% | 23.77% | 21.22% | 20.05% |
Profit Margin | -5.11% | -11.12% | 14.57% | 19.63% | 17.02% | 15.80% |
FCF Margin | 12.02% | 20.66% | -11.85% | 12.99% | 35.77% | 16.74% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.200 | 0.200 | 0.500 | 1.500 | 1.000 | 0.700 |
Dividend Per Share Growth | -60.00% | -60.00% | -66.67% | 50.00% | 42.86% | 100.00% |
Dividend Yield | 1.69% | 1.35% | 2.44% | 5.77% | 4.34% | 4.33% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | - | 24.32 | 13.56 | 15.53 | 13.47 |
Forward PE | - | 10.63 | 10.63 | 10.63 | 10.63 | 10.63 |
P/FCF Ratio | 20.85 | 18.01 | - | 20.49 | 7.39 | 12.71 |
PS Ratio | 2.51 | 3.72 | 3.54 | 2.66 | 2.64 | 2.13 |